Follow-Ons/Rights Issues

  • Chinese pharma names flock to ECM market

    Chinese pharma names flock to ECM market

    There was a burst of activity from Chinese pharmaceutical and biotechnology companies in the equity capital markets this week, as the sector took centre stage following the spread of a flu-like virus that has already claimed lives on the mainland. Jonathan Breen reports.

  • Intu preps rescue rights issue but needs a long-term plan

    Intu preps rescue rights issue but needs a long-term plan

    Intu, the British real estate and investment trust focused on shopping centres, has confirmed it will be tapping its shareholders for equity capital in February, but sources say the company needs to outline its vision for its future, given the headwinds buffeting the UK retail sector.

  • Seazen pockets $351m from HK placement

    Seazen pockets $351m from HK placement

    Chinese property developer Seazen Group raised HK$2.73bn ($351.3m) on Monday from a sale of new shares, increasing the offering size on the back of strong demand, according to a source familiar with the deal.

  • Investors put in jumbo orders for Airtel’s $3bn QIP, CB combo

    Investors put in jumbo orders for Airtel’s $3bn QIP, CB combo

    Indian telecommunications giant Bharti Airtel made a splash in the equities market this week, bagging $2bn from a qualified institutional placement (QIP) and $1bn from a convertible bond, the first equity-linked issue in the country in more than two years. Both the deals received a big thumbs-up from investors, reports Jonathan Breen.

All Articles